Key result
FIRM-guided ablation fails to improve freedom from AF or AT recurrence over conventional PVI alone.
Why the study?
Pulmonary vein isolation is not curative in many patients with persistent atrial fibrillation, and the added benefit of ablation targeting focal and rotational drivers is uncertain.
Does adding Focal Impulse and Rotor Modulated (FIRM) ablation to conventional ablation improve freedom from atrial fibrillation/atrial tachycardia recurrence in patients with persistent atrial fibrillation?
RCT (n=350)
Single-blind
Block randomization using a web-based database system, stratified per site
Yes
Does adding Focal Impulse and Rotor Modulated (FIRM) ablation to conventional ablation improve freedom from atrial fibrillation/atrial tachycardia recurrence in patients with persistent atrial fibrillation?
Answers are grounded in this paper and cite their sources.
The addition of Focal Impulse and Rotor Modulated (FIRM) ablation to conventional ablation did not significantly improve freedom from atrial fibrillation or atrial tachycardia recurrence in patients with persistent atrial fibrillation.
Background Pulmonary vein isolation (PVI) is the cornerstone therapy for symptomatic drug‐refractory atrial fibrillation yet is not curative in a large segment of patients. Focal and rotational drivers are proposed to be involved in atrial fibrillation mechanisms but their ablation has produced variable outcomes. REAFFIRM (The Randomized Evaluation of Atrial Fibrillation Treatment with Focal Impulse and Rotor Modulation Guided Procedures) trial (NCT‐02274857) objective was to compare the safety and effectiveness of conventional ablation with and without Focal Impulse and Rotor Modulated (FIRM) ablation, guided by global basket mapping, for the treatment of persistent atrial fibrillation. Methods Three hundred seventy‐five patients were enrolled and randomized at 18 centers. The Intent‐to‐Treat population consisted of 350 patients (171 FIRM, 179 Conventional). Primary effectiveness was defined as single procedure freedom from atrial fibrillation/atrial tachycardia recurrence at 3 to 12 months post index procedure. Results Three hundred twenty‐four patients completed the 12‐month follow‐up. Patients in the FIRM arm had a larger left atrium ( P <0.01). Primary effectiveness at 3 to 12 months was 69.3% in FIRM and 67.5% in Conventional (NS), with no difference in ablation procedure time or safety. A subset of patients (41% FIRM, 49% Conventional) received extra ablation. Primary effectiveness in the on‐treatment subgroups was 65% PVI‐only, 69.6% PVI +extra, 77.7% FIRM+ PVI‐only, and 57.7% FIRM+ PVI +extra ( P =0.09). Conclusions Intention‐to‐treat analysis failed to provide evidence for the superiority of adding ablation of focal or rotational sites to conventional ablation. Registration URL: https://clinicaltrials.gov ; Unique Identifier: NCT‐02274857.
No takes yet. Share an insight, caveat, or question.
Brachmann et al. (2025) conducted an RCT in Persistent Atrial Fibrillation (n=350). Focal Impulse and Rotor Modulated (FIRM) ablation followed by pulmonary vein isolation (PVI) vs. Conventional ablation (PVI alone) was evaluated on Single procedure freedom from AF/AT recurrence at 3 to 12 months post index procedure (p=0.9618). FIRM-guided ablation followed by pulmonary vein isolation did not improve single procedure freedom from atrial fibrillation or atrial tachycardia recurrence at 3 to 12 months compared to conventional pulmonary vein isolation alone.
Synapse has enriched 10 related papers. Consider them for comparative context: